Hans Biomed Corp. engages in the manufacture and sale of graft material and silicon products. Its products include skin and bone graft material, silicon material, and other medical appliances. The company was founded on September 15, 1999, and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company